---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-000137"
form_type: "8-K"
ticker: "SGMT"
cik: "0001400118"
company_name: "Sagimet Biosciences Inc."
filed_at: "2025-01-02T23:59:59+00:00"
generated_at: "2026-05-28T18:04:45.764484+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "medium"
source: SEC EDGAR
---

# Sagimet issues updated January 2025 investor slide deck on MASH, acne, and cancer pipeline

## Summary
- Updated slide presentation dated January 2025 addresses metabolic dysfunction therapies for MASH, acne, and oncology.
- Presentation will be used in investor meetings; no financial results or clinical milestones disclosed in the filing.
- No specific data, guidance, or material events announced; update appears to be routine corporate presentation refresh.

## SEC filing metadata
- accession: 0001104659-25-000137
- form_type: 8-K
- ticker: SGMT
- cik: 0001400118
- company_name: Sagimet Biosciences Inc.
- filed_at: 2025-01-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1400118/000110465925000137/0001104659-25-000137-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1400118/000110465925000137/tm2431774d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-000137
- JSON: https://secwatch.observer/filing/0001104659-25-000137.json
- Plain text: https://secwatch.observer/filing/0001104659-25-000137.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.